WHO lists Pfizer vaccine for emergency use
The WHO’s review found Pfizer-BioNTech’s vaccine met the “must-have” criteria for safety and efficacy benefits outweigh its risks
This is the first time that a Covid-19 vaccine has been added to the WHO list.
The WHO’s review found Pfizer-BioNTech’s vaccine met the “must-have” criteria for safety and efficacy benefits outweigh its risks.
“Regulatory experts convened by WHO from around the world and WHO’s own teams reviewed the data on the Pfizer/BioNTech vaccine’s safety, efficacy and quality as part of a risk-versus-benefit analysis. The review found that the vaccine met the must-have criteria for safety and efficacy set out by WHO, and that the benefits of using the vaccine to address Covid-19 offset potential risks,” the WHO informs.
It is also noted that such validation of the vaccine “opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.”
As we reported earlier, president of Ukraine Volodymyr Zelensky told the press why Ukraine made a deal with Chinese company Sinovac Biotech, which foresees that the vaccine against Covid-19 will be supplied to this country before the veccine itself is registered.
“All countries all over the world do it, with all vaccines: they make contracts on certain volumes [of vaccine] as soon as it’s clear it’s going to be an efficient drug. And supplies and inoculations will kick off immedtiately after thee official procedures are over, so that no precious time is lost,” Zelensky said.